The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-Analysis

[1] Dansinger ML(2007)Meta-analysis: the effect of dietary counseling for weight loss Ann Intern Med 147 41-50

[2] Tatsioni A(2014)Recent advances in clinical practice challenges and opportunities in the management of obesity Gut 63 687-695

[3] Wong JB(2016)Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis JAMA 315 2424-2434

[4] Acosta A(2013)Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes BMC Med 11 1-133

[5] Dayyeh BKA(2006)BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients Int J Obes 30 129-846

[6] Port JD(2008)Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis Obes Surg 18 841-760

[7] Khera R(2012)Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study Gastrointest Endosc 76 756-31

[8] Murad MH(2011)Intragastric balloon therapy in the management of obesity: why the bad wrap? JPEN J Parenter Enteral Nutr 35 25-1570

[9] Chandar AK(2013)An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study Obesity 21 1561-1853

[10] Neff K(2016)Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study Obesity 24 1849-953

[1] Dansinger ML(2007)Meta-analysis: the effect of dietary counseling for weight loss Ann Intern Med 147 41-50

[2] Tatsioni A(2014)Recent advances in clinical practice challenges and opportunities in the management of obesity Gut 63 687-695

[3] Wong JB(2016)Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis JAMA 315 2424-2434

[4] Acosta A(2013)Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes BMC Med 11 1-133

[5] Dayyeh BKA(2006)BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients Int J Obes 30 129-846

[6] Port JD(2008)Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis Obes Surg 18 841-760

[7] Khera R(2012)Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study Gastrointest Endosc 76 756-31

[8] Murad MH(2011)Intragastric balloon therapy in the management of obesity: why the bad wrap? JPEN J Parenter Enteral Nutr 35 25-1570

[9] Chandar AK(2013)An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study Obesity 21 1561-1853

[10] Neff K(2016)Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study Obesity 24 1849-953